versus Placebo in the Treatment of Severe Perennial Allergic Rhinitis

Sixty patients took part in a randomized double-blind comparison of azatadine/pseudoephedrine versus placebo for the treatment of severe perennial allergic rhinitis. After 2 weeks of therapy subjective patient appraisal as well as objective physician evaluation showed the active drug combination to have a beneficial effect (72 % good to excellent improvement versus 40 % for placebo) in reducing the signs and symptoms of this allergic disorder. No adverse reactions were reported